Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)
- Citation:
- J Clin Pharmacol vol 60 (4) 444-52
- Year:
- 2020
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 9
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, CA025224, U10CA032291, U10CA041287, U10CA077651, U10CA108068, U10CA138561, U10CA180790, U10CA180791, 5UG1CA189830, U10CA180836, U10CA180867, K12CA139160
- Corr. Author:
- Authors:
- Manish R. Sharma Shailly Mehrotra Elizabeth Gray Kehua Wu William T. Barry Clifford Hudis Eric P. Winer Alan P. Lyss Deborah L. Toppmeyer Alvaro Moreno-Aspitia Thomas E. Lad Mario Velasco Beth Overmoyer Hope S. Rugo Mark J. Ratain Jogarao V. Gobburu
- Networks:
- CA136, CRCWM, HEARTLAND, IL018, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NY016, MD015, STROGER
- Study
- CALGB-40502
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: